Antidyslipidemic activity of furano-flavonoids isolated from Indigofera tinctoria

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 13, 2006, Pages 3411-3414

  Narender, Tadigoppula ^a   Khaliq, Tanvir ^a   Puri, Anju ^b   chander, Ramesh ^b  

^a Medicinal Chemistry Division   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Antidyslipidemic activity; Furano flavonoids; Hamster model

Indexed keywords

CHOLESTEROL; FATTY ACID; FENOFIBRATE; FLAVONOID; FLAVONOID GLYCOSIDE; GLYCEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; GLYCEROL BLOOD LEVEL; INDIGOFERA; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL;

ADMINISTRATION, ORAL; ANIMALS; ANTILIPEMIC AGENTS; CHOLESTEROL; CRICETINAE; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS; FLAVONOIDS; FURANS; GLYCEROL; INDIGOFERA; MOLECULAR STRUCTURE; PLANT EXTRACTS; PLANTS, MEDICINAL; STEREOISOMERISM; TRIGLYCERIDES;

CRICETINAE; INDIGOFERA TINCTORIA;

EID: 33646825187     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.04.001     Document Type: Article

References (38)

1. Eghdamian E., and Ghose K. Drugs Today 34 (1998) 943
2. Di Carlo G., Madcolo N., Izzo A.A., and Capasso F. Life Sci. 65 (1999) 337
3. Havesteen B. Biochem. Pharmacol. 32 (1983) 1141
4. Bors W., Heller W., Michel C., and Saran M. Methods Enzymol. 186 (1990) 343
5. Di Perri T., and Auteri A. Int. Angiol. 7 (1988) 11
6. Nishino H., Nagao M., Fujiki H., and Sugimura T. Cancer Lett. 21 (1983) 1
7. Hertog M.G.L., Feskens E.J.M., Hollman P.C.H., Katan M.B., and Kromhout D. Lancet 342 (1993) 1007
8. Hertog M.G.L., Kromhout D., Aravanis C., Blackbum H., Buzina R., Fidanza F., and Giampaoli S. Arch. Intern. Med. 155 (1995) 381
9. Knekt P., Jarvine R., Reunanen A., and Maatela L. J. Brit. Med. 312 (1996) 478
10. Monforte M.T., Trovato A., Kirjavainen S., Forestieri A.M., Galati E.M., and LoCurto R.B. Farmaco 50 (1995) 595
11. Bok S.H., Lee S.H., Park Y.B., Bae K.H., Son K.H., Jeong T.S., and Choi M.S. J. Nutr. 129 (1999) 1182
12. Wilcox L.J., Borradaile N.M., de Dreu L.F., and Hu M.W.J. Lipid Res. 42 (2001) 725
13. Borradaile N.M., Carroll K.K., and Kurowska E.M. Lipids 34 (1999) 591
14. Lee S.H., Park Y.B., Bea K.H., Bok S.H., Kwon Y.K., Lee E.S., and Choi M.S. Ann. Nutr. Metab. 43 (1999) 173
15. Lee M.K., Moon S.S., Lee S.E., Bok S.H., Jeong T.S., Park Y.B., and Choi M.S. Bioorg. Med. Chem. 11 (2003) 393
16. Kirtikar; Basu, Indian Medicinal Plants, part I, 712.
17. Kamal R., and Mangla M. Pharmazie 42 (1987) 356
18. Kamal R., and Mangla M. J. Biosci. 18 (1993) 93
19. Sreepriya M., Devaki T., Balakrishna K., and Apparananthan T. Indian J. Exp. Biol. 39 (2001) 181
20. Singh B., Saxena A.K., Chandan B.K., Bhardwaj V., Gupta V.N., Suri O.P., and Handa S.S. Phytother. Res. 15 (2001) 294
21. Puri, A.; Khaliq, T.; Bhatia, G.; Rajendran, Chander, R.; Narender, T. J. Herb. Pharmacotherapy 2006 to be printed in Vol. 6, Issue No. 4.
22. 3), δ 1.13 (s, 3H, Me) 1.32 (s, 3H, Me), 2.02 (s, 3H, OAc), 4.25 (d, J = 6 Hz, 1H, H-3″), 5.62 (s, 1H, H-4″), 6.62 (d, J = 8 Hz, 1H, H-2″), 6.70 (s, 1H, H-3), 6.90 (d, J = 8 Hz, 1H, H-6), 7.50-7.54 (m, 3H, H-3′-5′), 7.88-7.93 (m, 2H, H-2′,6′), 8.10 (d, J = 10 Hz, 1H, H-5); FAB Mass: 393 (M+1).
23. Rao E.V., and Raju N.R. Phytochemistry 23 (1984) 2339
24. Pelter A., Ward R.S., Rao E.V., and Raju N.R. J. Chem Soc. PT I (1981) 2491
25. Rao P.S., and Rao G.V. Fitoterapia LVI (1985) 175
26. Jonathan L.T., Gbearsor M., Che C.T., Fong H.H., Farnsworth N.R., Le Breton G.C., and Venton D.L. J. Nat. Prod. 53 (1990) 1572
27. Pirrung M.C., and Lee Y.R. J. Am. Chem. Soc. 117 (1995) 4814
28. For experimental procedure for biological activity, please see ref. Narender T., Puri A., Shweta, Khaliq T., Bhatia G., and Chander R. Bioorg. Med. Chem. Lett 16 (2006) 293
29. Rizvi R., Puri A., Bhatia G., Khanna A.K., Wulf E.M., Rastogi A.K., and Chander R. Biochem. Biophys. Res. Commun. 305 (2003) 215
30. Bhatia G., Rizvi F., Saxena R., Puri A., Khanna A.K., Chander R., Wulf E.M., and Rastogi A.K. Ind. J. Exp. Biol. 41 (2003) 1456
31. Buccolo G., and David H. Clin. Chem. 29 (1973) 1798
32. Deeg R., and Ziegenhorn J. Clin. Chem. 29 (1983) 476
33. Gowan M.W., Artiss J.D., Strandbergh D.R., and Zak B. Clin. Chem. 29 (1983) 538
34. Wako pure Chemical Limited. NAFAC, Quantitative determination of free fatty acid in serum by ACS-ACO Method Company code No. 994-75409E.
35. Gordon D.J., Probstfield J.L., Garrison R.J., Neatom J.D., Jacob D.R., Bangdiwala Jr. S., and Tyroler H.A. Circulation 79 (1989) 8
36. Elokdah H., Sulkowski T.S., Gharbia M.A., Butera J.A., Chai S.Y., McFarlane G.R., McKean M.C., Babiak J.L., Adelman S.J., and Quinet E.M. J. Med. Chem. 47 (2004) 681
37. Koyama H., Miller D.J., Boueres J.K., Desai R.C., et al. J. Med. Chem. 47 (2004) 3255
38. Data were analyzed by Graph Pad Prism Version 3.02 (Graph Pad Software Inc); The percentage of lowering of lipids calculated as below:{A formula is presented}A = HFD fed animal's lipid values B = Drug (flavonoids) and HFD fed animal's lipid values.